Loading clinical trials...
Loading clinical trials...
Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Bialystok
NCT07276711 · Aortic Valve Stenosis, Aortic Stenosis, and more
NCT06168370 · Severe Aortic Valve Stenosis
NCT04761120 · Mitral Regurgitation, Tricuspid Regurgitation, and more
NCT05956652 · Aortic Valve Stenosis
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital
Bialystok
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions